JAMIE COLLINS: Open Payments
NPI 1124783329 · BEAUMONT, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$271 in 8 payments from 5 companies in 2025. Trend: 2023 $122 · 2024 $142 · 2025 $271
Food & beverage: $271
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 2 | $113 |
| Axsome Therapeutics, Inc. | 1 | $70 |
| ABBVIE INC. | 2 | $35 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
Products named: INGREZZA, Auvelity, VRAYLAR, AUSTEDO XR, ABILIFY ASIMTUFII, REXULTI.
Industry payments across TX — which companies pay providers there.
